Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
As of: Sep 4, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Non-Current Deffered Revenue (2016 - 2020)

Argenx Se's (ARGX) quarterly Non-Current Deffered Revenue came in at -$269.0 million in Q4 2021, down 202.92% YoY from $261.4 million in Q4 2020, and little changed on a QoQ basis from -$269.0 million in Q2 2021.

Analysis

Argenx Se (ARGX) Non-Current Deffered Revenue (2016 - 2020) Analysis & Trends

Argenx Se (ARGX) has 6 years of Non-Current Deffered Revenue data on file, last reported at -$269.0 million in Q4 2021.

  • Quarterly Non-Current Deffered Revenue fell 202.92% year-over-year to -$269.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$269.0 million (down 202.92% YoY) and the FY2021 annual result came in at -$269.0 million, down 200.0% from the prior year.
  • Non-Current Deffered Revenue held at -$269.0 million in Q4 2021, from -$269.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $267.1 million in Q2 2019 to a low of -$269.0 million in Q2 2021.
  • A 5-year average of $26.8 million and a median of $25855.9 in 2018 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2019 — Non-Current Deffered Revenue jumped 14834.5% — and 2021, when it tumbled 1477.94%.
  • Tracing ARGX's Non-Current Deffered Revenue over 5 years: stood at $1.7 million in 2017, then tumbled by 196.94% to -$1.6 million in 2018, then jumped by 14834.5% to $241.3 million in 2019, then climbed by 8.32% to $261.4 million in 2020, then slumped by 202.92% to -$269.0 million in 2021.
  • The last three Non-Current Deffered Revenue figures came in at -$269.0 million (Q4 2021), -$269.0 million (Q2 2021), and $261.4 million (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 261.41 Bn
Jun 30, 2020 223.11 Mn
Dec 31, 2019 241.34 Mn
Jun 30, 2019 267.05 Mn
Dec 31, 2017 1.69 Mn
Dec 31, 2016 10.87 Mn